Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms

Conclusions Combined therapy with tamsulosin OCAS 0.4mg daily and solifenacin 5mg daily is a safe and well-tolerated management for stent-related symptoms. However, stent position remains a significant factor affecting response to medical therapy and patients’ health-related quality of life.
Source: Arab Journal of Urology - Category: Urology & Nephrology Source Type: research